PLSH.US Panacea Life Sciences Holdings Inc

Healthcare Pharmaceuticals USA Stocks
0.0828 USD
Close of Nov 12, 2026
0.0211 0.1400
Market cap
USD 4.92M
P/E
-
P/B
0.47x
ROE
42.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2025.

Is PLSH.US undervalued?

Graham number

The Graham number of Panacea Life Sciences Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Panacea Life Sciences Holdings Inc fundamental analysis

No fundamental analysis for Panacea Life Sciences Holdings Inc yet.

Panacea Life Sciences Holdings Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Panacea Life Sciences Holdings Inc

Panacea Life Sciences Holdings, Inc., operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals. It provides a range of products, including Nitro Kava, Kratom, hemp, VAPE products, and various beverages that focuses on promoting alternative health and wellness. The company also offers natural remedies under the PANA Health, PANA …

Full company profile